FDA advisers to weigh updated COVID vaccine targeting XFG subvariant
The Food and Drug Administration’s (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respiratory viral season. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on Thursday to discuss whether COVID-19 vaccines should target the NB.1.8.1…
Original Source
Read the full article at Thehill →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.